Cancer Clinical Trials

Clinical trials are research studies in which people help doctors find ways to improve health and cancer care. Each study tries to answer scientific questions and to find better ways to prevent, diagnose or treat cancer. Learn more about the different types and phases of clinical trials.

Why should I participate in a clinical trial?

Today it is possible to enroll in a clinical trial as the first step in your treatment after a cancer diagnosis. There are literally hundreds of trials available across the country. In fact, many of our most effective treatments used today for breast, colon, rectal and childhood cancers are the result of recent successes in clinical trials. As a participant a patient has the opportunity to help further the cause for other cancer patients, and possibly be helped by the treatments they receive. Participation in a clinical trial is voluntary. 

Below is a listing current treatment clinical trials for cancer offered through the Genesis Cancer Care Institute and Iowa Cancer Specialists. See clinical trials offered by Hematology-Oncology Associates of the Quad-Cities, PC

Each trial below is linked to a complete description provided by the National Cancer Institute. If you need assistance with this process, contact us

You may search for other clinical trials through the following links: National Cancer Institute Clinical Trial Search; Emerging Med; Trial Check; or Center Watch.

Showing 1-10 of 60

Sorted By:

  • Breast Cancer Trial: ECOG-ACRIN E2112

    Randomized Phase III Trial of Endocrine Therapy plus Entinostat/Placebo in Postmenopausal Patients with Hormone Receptor-Positive Advanced Breast Cancer

  • Breast Cancer Trial: NSABP B-47

    A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel + Cyclophosphamide or Four Cycles of Doxorubicin + Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy + Trastuzumab in Women With Node-Positive or High Risk Node-Negative HER2-Low Invasive Breast Cancer

  • Breast Cancer Trial: SWOG S1007

    A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER-2 Negative Breast Cancer (RS) of 25 or Less – Step 1 with Recurrence Score

  • Breast Cancer Trial: SWOG S1207

    Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of EVEROLIMUS in Patients with High-Risk, Homone Receptor-Positive AND HER2/neu Negative Breast Cancer

  • Breast Cancer: E2112

    The purpose of this study is find out what effects, both good and bad, an experimental drug called entinostat has on patients with breast cancer that is not able to be removed by surgery or has spread to another part of the body, when given together with the standard hormonal drug treatment, exemestane.

  • Breast Cancer: E2112

    The purpose of this study is find out what effects, both good and bad, an experimental drug called entinostat has on patients with breast cancer that is not able to be removed by surgery or has spread to another part of the body, when given together with the standard hormonal drug treatment, exemestane.

  • Breast Cancer: NSABP B-47

    The main purpose of this study is to learn if adding a targeted therapy, trastuzumab (Herceptin®), to standard treatment with chemotherapy for early stage, HER2-low breast cancer, will prevent breast cancer from returning.

  • Breast Cancer: S1007

    The purpose of this study is to determine the effect of chemotherapy in patients with node positive breast cancer who do not have high Recurrence Scores (RS) by Oncotype DX.

  • Breast Cancer: S1207

    The purpose of this study is to see whether treatment with everolimus plus hormone treatment after chemotherapy will increase the time without cancer returning for patients with hormone responsive breast cancer that have had their cancer removed by surgery and have completed required chemotherapy or radiation.

  • Breast Cancer: S1207

    The purpose of this study is to see whether treatment with everolimus plus hormone treatment after chemotherapy will increase the time without cancer returning for patients with hormone responsive breast cancer that have had their cancer removed by surgery and have completed required chemotherapy or radiation.

Page of 6, showing trials 1-10 of 60

Contact Us

For more information about our cancer services, please contact:

563-421-1909
800-446-6088
Email

Related Locations

Cancer Nurse Navigators

Cancer Nurse Navigators

Do you or a loved one have cancer? Let our Cancer Nurse Navigators guide the way. Call us today.

563-421-1029
563-421-1030

Learn More

Related Classes/Events

  • May
    2
    Saturday
    8:00 AM - 8:15 AM
    May is National Melanoma and Skin Cancer Detection and Prevention Month. Quad City area residents are encouraged to participate in a free skin cancer screening.
  • May
    2
    Saturday
    8:15 AM - 8:30 AM
    May is National Melanoma and Skin Cancer Detection and Prevention Month. Quad City area residents are encouraged to participate in a free skin cancer screening.
  • May
    2
    Saturday
    8:30 AM - 8:45 AM
    May is National Melanoma and Skin Cancer Detection and Prevention Month. Quad City area residents are encouraged to participate in a free skin cancer screening.

Dietitian's Blog

Teresa Pangan

Teresa Pangan, Cancer Care Dietitian, can help you incorporate healthy eating habits into your cancer care plan. 

Read Teresa's most recent post here.